瑞银：将艾伯维(ABBV.N)评级下调至中性，目标价上调至147美元

媒体滚动2022-03-01

瑞银分析师Colin Bristow将艾伯维(ABBV.N)评级从买入下调至中性，目标价从129美元上调至147美元。该分析师很难找到"该股的上涨空间"，称其估值相对于同行来说不再便宜。Bristow称，艾伯维的股票已开始计入该公司囊性纤维化产品线带来的一些调整后的收入，这意味着该公司的股价可能出现下跌。Bristow表示，福泰制药(VRTX.N)在该领域设立的“高标杆”，让人不太容易相信艾伯维在...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2216193444?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2022-03-01 02:26","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2216193444","market":"hk","top_or_hot":-1,"title":"瑞银：将艾伯维(ABBV.N)评级下调至中性，目标价上调至147美元","media":"媒体滚动","content":"<div>\n<p>瑞银分析师Colin Bristow将艾伯维(ABBV.N)评级从买入下调至中性，目标价从129美元上调至147美元。该分析师很难找到\"该股的上涨空间\"，称其估值相对于同行来说不再便宜。Bristow称，艾伯维的股票已开始计入该公司囊性纤维化产品线带来的一些调整后的收入，这意味着该公司的股价可能出现下跌。Bristow表示，福泰制药(VRTX.N)在该领域设立的“高标杆”，让人不太容易相信艾伯维在...</p>\n\n<a href=\"https://cj.sina.cn/article/normal_detail?url=https://finance.sina.com.cn/7x24/2022-03-01/doc-imcwiwss3455352.shtml\">网页链接</a>\n\n</div>\n","source":"sina_symbol","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>瑞银：将艾伯维(ABBV.N)评级下调至中性，目标价上调至147美元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n瑞银：将艾伯维(ABBV.N)评级下调至中性，目标价上调至147美元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-03-01 02:26 北京时间&nbsp;&nbsp;&nbsp;<a href=https://cj.sina.cn/article/normal_detail?url=https://finance.sina.com.cn/7x24/2022-03-01/doc-imcwiwss3455352.shtml><strong>媒体滚动</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>瑞银分析师Colin Bristow将艾伯维(ABBV.N)评级从买入下调至中性，目标价从129美元上调至147美元。该分析师很难找到\"该股的上涨空间\"，称其估值相对于同行来说不再便宜。Bristow称，艾伯维的股票已开始计入该公司囊性纤维化产品线带来的一些调整后的收入，这意味着该公司的股价可能出现下跌。Bristow表示，福泰制药(VRTX.N)在该领域设立的“高标杆”，让人不太容易相信艾伯维在...</p>\n\n<a href=\"https://cj.sina.cn/article/normal_detail?url=https://finance.sina.com.cn/7x24/2022-03-01/doc-imcwiwss3455352.shtml\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ABBV","symbol_name":"艾伯维公司","start_time":0,"source_url":"https://cj.sina.cn/article/normal_detail?url=https://finance.sina.com.cn/7x24/2022-03-01/doc-imcwiwss3455352.shtml","article_id":"2216193444","we_media_id":null,"thumbnails":[],"rights":{"source":"sina_symbol","url":"https://cj.sina.cn/article/normal_detail?url=https://finance.sina.com.cn/7x24/2022-03-01/doc-imcwiwss3455352.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.title{#titleStyle#}a{#lv2TextColor#}.extra-info, .source{#sourceStyle#;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2216193444","pubTimestamp":1646072786,"sourceInfo":{"source_id":"sina_symbol","name":"新浪媒体新闻"},"weMediaInfo":null,"summary":"瑞银分析师Colin Bristow将艾伯维(ABBV.N)评级从买入下调至中性，目标价从129美元上调至147美元。该分析师很难找到\"该股的上涨空间\"，称其估值相对于同行来说不再便宜。Bristow称，艾伯维的股票已开始计入该公司囊性纤维化产品线带来的一些调整后的收入，这意味着该公司的股价可能出现下跌。Bristow表示，福泰制药(VRTX.N)在该领域设立的“高标杆”，让人不太容易相信艾伯维在这个时候会带来竞争性。","collect":0,"end_time":0,"defaultTopTitle":"sina.cn","property":["rate"],"viewcount":null,"language":"zh","relate_stocks":{"ABBV":"艾伯维公司"},"translate_title":"UBS: downgraded ABBV.N to neutral and raised its target price to $147","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ABBV":1},"content_text":"瑞银分析师Colin Bristow将艾伯维(ABBV.N)评级从买入下调至中性，目标价从129美元上调至147美元。该分析师很难找到\"该股的上涨空间\"，称其估值相对于同行来说不再便宜。Bristow称，艾伯维的股票已开始计入该公司囊性纤维化产品线带来的一些调整后的收入，这意味着该公司的股价可能出现下跌。Bristow表示，福泰制药(VRTX.N)在该领域设立的“高标杆”，让人不太容易相信艾伯维在这个时候会带来竞争性。","kind":null,"is_publish_news":null,"is_publish_highlight":null,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2216193444"}